{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:55:13Z","timestamp":1792760113418,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":77,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biosci"],"DOI":"10.1186\/s13578-026-01576-1","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T05:06:31Z","timestamp":1776834391000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A mouse model of HPV-associated cervicovaginal carcinosarcoma with comparative analysis to human clinical cases"],"prefix":"10.1186","volume":"16","author":[{"given":"Jason","family":"Murray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiwen","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Fu","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.-C.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deyin","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"issue":"4","key":"1576_CR1","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.path.2009.08.016","volume":"2","author":"RA Soslow","year":"2009","unstructured":"Soslow RA. Mixed mullerian tumors of the female genital tract. Surg Pathol Clin. 2009;2(4):707\u201330.","journal-title":"Surg Pathol Clin"},{"issue":"3","key":"1576_CR2","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/00004347-199807000-00004","volume":"17","author":"PB Clement","year":"1998","unstructured":"Clement PB, et al. Malignant mullerian mixed tumors of the uterine cervix: a report of nine cases of a neoplasm with morphology often different from its counterpart in the corpus. Int J Gynecol Pathol. 1998;17(3):211\u201322.","journal-title":"Int J Gynecol Pathol"},{"issue":"3","key":"1576_CR3","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/00000478-199603000-00003","volume":"20","author":"L Thompson","year":"1996","unstructured":"Thompson L, Chang B, Barsky SH. Monoclonal origins of malignant mixed tumors (carcinosarcomas). Evidence for a divergent histogenesis. Am J Surg Pathol. 1996;20(3):277\u201385.","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"1576_CR4","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.jtho.2017.03.005","volume":"12","author":"AB Schrock","year":"2017","unstructured":"Schrock AB, et al. Pulmonary sarcomatoid carcinomas commonly harbor either potentially targetable genomic alterations or high tumor mutational burden as observed by comprehensive genomic profiling. J Thorac Oncol. 2017;12(6):932\u201342.","journal-title":"J Thorac Oncol"},{"issue":"3","key":"1576_CR5","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/01.pas.0000184809.27735.a1","volume":"30","author":"MR Carter","year":"2006","unstructured":"Carter MR, et al. Spindle cell (sarcomatoid) carcinoma of the breast: a clinicopathologic and immunohistochemical analysis of 29 cases. Am J Surg Pathol. 2006;30(3):300\u20139.","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"1576_CR6","doi-asserted-by":"publisher","first-page":"e557","DOI":"10.1016\/j.athoracsur.2016.05.095","volume":"102","author":"S Oka","year":"2016","unstructured":"Oka S, et al. Complete resection of thymic sarcomatoid carcinoma through total aortic arch replacement. Ann Thorac Surg. 2016;102(6):e557\u20139.","journal-title":"Ann Thorac Surg"},{"key":"1576_CR7","doi-asserted-by":"crossref","unstructured":"Hoseini SS, Tang X, Dewar R. Sarcomatoid carcinoma of small intestine. BMJ Case Rep. 2025;18(1):e261160.","DOI":"10.1136\/bcr-2024-261160"},{"issue":"10","key":"1576_CR8","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1097\/01.pas.0000209838.92842.bf","volume":"30","author":"DE Hansel","year":"2006","unstructured":"Hansel DE, Epstein JI. Sarcomatoid carcinoma of the prostate: a study of 42 cases. Am J Surg Pathol. 2006;30(10):1316\u201321.","journal-title":"Am J Surg Pathol"},{"key":"1576_CR9","doi-asserted-by":"crossref","unstructured":"Lee JW et al. Trends in gynecologic carcinosarcoma based on analysis of the surveillance epidemiology end result (SEER) Database. J Clin Med. 2023;12(3):1188.","DOI":"10.3390\/jcm12031188"},{"key":"1576_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.gore.2025.101679","volume":"57","author":"ENB Pham","year":"2025","unstructured":"Pham ENB, et al. Quality of life and survival in patients with uterine carcinosarcoma: a tertiary center observational study. Gynecol Oncol Rep. 2025;57:101679.","journal-title":"Gynecol Oncol Rep"},{"issue":"3","key":"1576_CR11","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s00432-019-03091-y","volume":"146","author":"V Heinzelmann-Schwarz","year":"2020","unstructured":"Heinzelmann-Schwarz V, et al. Should MMMT still be treated with adjuvant taxane-based combination chemotherapy? J Cancer Res Clin Oncol. 2020;146(3):695\u2013704.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"1576_CR12","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/j.1525-1438.2006.00760.x","volume":"17","author":"MS Mano","year":"2007","unstructured":"Mano MS, et al. Current management of ovarian carcinosarcoma. Int J Gynecol Cancer. 2007;17(2):316\u201324.","journal-title":"Int J Gynecol Cancer"},{"key":"1576_CR13","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/470795","volume":"2011","author":"R Kanthan","year":"2011","unstructured":"Kanthan R, Senger JL. Uterine carcinosarcomas (malignant mixed mullerian tumours): a review with special emphasis on the controversies in management. Obstet Gynecol Int. 2011;2011:470795.","journal-title":"Obstet Gynecol Int"},{"issue":"3","key":"1576_CR14","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/cjp2.18","volume":"1","author":"MK McConechy","year":"2015","unstructured":"McConechy MK, et al. In-depth molecular profiling of the biphasic components of uterine carcinosarcomas. J Pathol Clin Res. 2015;1(3):173\u201385.","journal-title":"J Pathol Clin Res"},{"key":"1576_CR15","doi-asserted-by":"publisher","first-page":"5006","DOI":"10.1038\/ncomms6006","volume":"5","author":"S Jones","year":"2014","unstructured":"Jones S, et al. Genomic analyses of gynaecologic carcinosarcomas reveal frequent mutations in chromatin remodelling genes. Nat Commun. 2014;5:5006.","journal-title":"Nat Commun"},{"issue":"3","key":"1576_CR16","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.ccell.2017.02.010","volume":"31","author":"AD Cherniack","year":"2017","unstructured":"Cherniack AD, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017;31(3):411\u201323.","journal-title":"Cancer Cell"},{"issue":"1","key":"1576_CR17","first-page":"114","volume":"60","author":"H Fujii","year":"2000","unstructured":"Fujii H, et al. Frequent genetic heterogeneity in the clonal evolution of gynecological carcinosarcoma and its influence on phenotypic diversity. Cancer Res. 2000;60(1):114\u201320.","journal-title":"Cancer Res"},{"issue":"3","key":"1576_CR18","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1097\/00000478-200103000-00008","volume":"25","author":"W Grayson","year":"2001","unstructured":"Grayson W, Taylor LF, Cooper K. Carcinosarcoma of the uterine cervix: a report of eight cases with immunohistochemical analysis and evaluation of human papillomavirus status. Am J Surg Pathol. 2001;25(3):338\u201347.","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"1576_CR19","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.humpath.2007.03.008","volume":"38","author":"M Sebenik","year":"2007","unstructured":"Sebenik M, et al. Malignant mixed mullerian tumor of the vagina: case report with review of the literature, immunohistochemical study, and evaluation for human papilloma virus. Hum Pathol. 2007;38(8):1282\u20138.","journal-title":"Hum Pathol"},{"issue":"17","key":"1576_CR20","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1042\/CS20160786","volume":"131","author":"SV Graham","year":"2017","unstructured":"Graham SV. The human papillomavirus replication cycle, and its links to cancer progression: a comprehensive review. Clin Sci (Lond). 2017;131(17):2201\u201321.","journal-title":"Clin Sci (Lond)"},{"issue":"10","key":"1576_CR21","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1002\/ijc.29971","volume":"138","author":"SR Skinner","year":"2016","unstructured":"Skinner SR, et al. Progression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE study. Int J Cancer. 2016;138(10):2428\u201338.","journal-title":"Int J Cancer"},{"issue":"12","key":"1576_CR22","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.trecan.2020.07.007","volume":"6","author":"K Lohmussaar","year":"2020","unstructured":"Lohmussaar K, Boretto M, Clevers H. Human-Derived Model Systems in Gynecological Cancer Research. Trends Cancer. 2020;6(12):1031\u201343.","journal-title":"Trends Cancer"},{"issue":"17","key":"1576_CR23","doi-asserted-by":"publisher","first-page":"4560","DOI":"10.1158\/0008-5472.CAN-21-0399","volume":"81","author":"TR Henkle","year":"2021","unstructured":"Henkle TR, et al. Development of a novel mouse model of spontaneous high-risk HPVE6\/E7-expressing carcinoma in the cervicovaginal tract. Cancer Res. 2021;81(17):4560\u20139.","journal-title":"Cancer Res"},{"issue":"8","key":"1576_CR24","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1097\/IGC.0000000000000525","volume":"25","author":"LI Larmour","year":"2015","unstructured":"Larmour LI, Jobling TW, Gargett CE. A review of current animal models for the study of cervical dysplasia and cervical carcinoma. Int J Gynecol Cancer. 2015;25(8):1345\u201352.","journal-title":"Int J Gynecol Cancer"},{"issue":"43","key":"1576_CR25","doi-asserted-by":"publisher","first-page":"E9076","DOI":"10.1073\/pnas.1712018114","volume":"114","author":"ME Spurgeon","year":"2017","unstructured":"Spurgeon ME, et al. Human papillomavirus oncogenes reprogram the cervical cancer microenvironment independently of and synergistically with estrogen. Proc Natl Acad Sci USA. 2017;114(43):E9076\u201385.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"1576_CR26","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12929-022-00864-5","volume":"29","author":"S Peng","year":"2022","unstructured":"Peng S, et al. Identification of human MHC-I HPV18 E6\/E7-specific CD8+ T cell epitopes and generation of an HPV18 E6\/E7-expressing adenosquamous carcinoma in HLA-A2 transgenic mice. J Biomed Sci. 2022;29(1):80.","journal-title":"J Biomed Sci"},{"issue":"4","key":"1576_CR27","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1097\/PAS.0000000000000565","volume":"40","author":"D Xing","year":"2016","unstructured":"Xing D, et al. Lower female genital tract tumors with adenoid cystic differentiation: P16 expression and high-risk HPV detection. Am J Surg Pathol. 2016;40(4):529\u201336.","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"1576_CR28","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1097\/PAS.0000000000001042","volume":"42","author":"D Xing","year":"2018","unstructured":"Xing D, et al. Next-generation sequencing reveals recurrent somatic mutations in small cell neuroendocrine carcinoma of the uterine cervix. Am J Surg Pathol. 2018;42(6):750\u201360.","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"1576_CR29","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1097\/PAS.0000000000002367","volume":"49","author":"GA Williams 2nd","year":"2025","unstructured":"Williams GA 2nd, et al. Clinicopathologic features and viral status of low-risk HPV6 and HPV11-associated squamous cell carcinoma of the uterine cervix and vulva. Am J Surg Pathol. 2025;49(5):458\u201370.","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"1576_CR30","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1128\/jcm.30.4.987-992.1992","volume":"30","author":"M Evander","year":"1992","unstructured":"Evander M, et al. Comparison of a one-step and a two-step polymerase chain reaction with degenerate general primers in a population-based study of human papillomavirus infection in young Swedish women. J Clin Microbiol. 1992;30(4):987\u201392.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"1576_CR31","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1158\/2326-6066.CIR-16-0358","volume":"6","author":"YH Lin","year":"2018","unstructured":"Lin YH, et al. Integration of oncogenes via sleeping beauty as a mouse model of HPV16(+) oral tumors and immunologic control. Cancer Immunol Res. 2018;6(3):305\u201319.","journal-title":"Cancer Immunol Res"},{"issue":"6","key":"1576_CR32","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/ng.343","volume":"41","author":"L Mates","year":"2009","unstructured":"Mates L, et al. Molecular evolution of a novel hyperactive sleeping beauty transposase enables robust stable gene transfer in vertebrates. Nat Genet. 2009;41(6):753\u201361.","journal-title":"Nat Genet"},{"issue":"2","key":"1576_CR33","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1158\/0008-5472.CAN-08-1800","volume":"69","author":"SM Wiesner","year":"2009","unstructured":"Wiesner SM, et al. De novo induction of genetically engineered brain tumors in mice using plasmid DNA. Cancer Res. 2009;69(2):431\u20139.","journal-title":"Cancer Res"},{"issue":"10","key":"1576_CR34","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1016\/j.celrep.2019.02.004","volume":"26","author":"C He","year":"2019","unstructured":"He C, et al. A human papillomavirus-independent cervical cancer animal model reveals unconventional mechanisms of cervical carcinogenesis. Cell Rep. 2019;26(10):2636-2650 e5.","journal-title":"Cell Rep"},{"issue":"3","key":"1576_CR35","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1177\/10668969211037915","volume":"30","author":"R Kotoku","year":"2022","unstructured":"Kotoku R, et al. Two components of variant profiles in primary vaginal carcinosarcoma via next-generation sequencing and a literature review. Int J Surg Pathol. 2022;30(3):288\u201394.","journal-title":"Int J Surg Pathol"},{"issue":"6","key":"1576_CR36","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1111\/his.13822","volume":"74","author":"X Zhang","year":"2019","unstructured":"Zhang X, et al. Molecular profiling of the biphasic components of hepatic carcinosarcoma by the use of targeted next-generation sequencing. Histopathology. 2019;74(6):944\u201358.","journal-title":"Histopathology"},{"issue":"23","key":"1576_CR37","first-page":"5379","volume":"57","author":"H Wada","year":"1997","unstructured":"Wada H, et al. Molecular evidence that most but not all carcinosarcomas of the uterus are combination tumors. Cancer Res. 1997;57(23):5379\u201385.","journal-title":"Cancer Res"},{"issue":"3","key":"1576_CR38","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1159\/000052369","volume":"37","author":"S Halachmi","year":"2000","unstructured":"Halachmi S, et al. Genetic alterations in urinary bladder carcinosarcoma: evidence of a common clonal origin. Eur Urol. 2000;37(3):350\u20137.","journal-title":"Eur Urol"},{"issue":"1","key":"1576_CR39","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/modpathol.2008.176","volume":"22","author":"AB Armstrong","year":"2009","unstructured":"Armstrong AB, et al. TP53 mutational analysis supports monoclonal origin of biphasic sarcomatoid urothelial carcinoma (carcinosarcoma) of the urinary bladder. Mod Pathol. 2009;22(1):113\u20138.","journal-title":"Mod Pathol"},{"key":"1576_CR40","doi-asserted-by":"crossref","unstructured":"Wang J et al. Clinical features of sarcomatoid carcinoma (carcinosarcoma) of the urinary bladder: analysis of 221 cases. Sarcoma, 2010. 2010.","DOI":"10.1155\/2010\/454792"},{"issue":"5","key":"1576_CR41","volume":"16","author":"AM Badheeb","year":"2024","unstructured":"Badheeb AM, et al. Urinary bladder carcinosarcoma (sarcomatoid carcinoma) with long survival after transurethral resection: a case report. Cureus. 2024;16(5):e59992.","journal-title":"Cureus"},{"key":"1576_CR42","doi-asserted-by":"publisher","first-page":"1663811","DOI":"10.3389\/fonc.2025.1663811","volume":"15","author":"R Zhao","year":"2025","unstructured":"Zhao R, et al. Primary gastric SMARCA4-deficient carcinosarcoma and sarcomatoid carcinoma: Two case reports. Front Oncol. 2025;15:1663811.","journal-title":"Front Oncol"},{"issue":"1","key":"1576_CR43","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13000-020-00934-y","volume":"15","author":"J Hrudka","year":"2020","unstructured":"Hrudka J, Rosova B, Halaska MJ. Squamous cell carcinoma with sarcomatoid differentiation or carcinosarcoma of the uterine cervix associated with HPV33 infection: report of a rare case. Diagn Pathol. 2020;15(1):12.","journal-title":"Diagn Pathol"},{"issue":"10","key":"1576_CR44","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1097\/PAS.0b013e31828de23a","volume":"37","author":"M Miettinen","year":"2013","unstructured":"Miettinen M, et al. ERG expression in epithelioid sarcoma: a diagnostic pitfall. Am J Surg Pathol. 2013;37(10):1580\u20135.","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"1576_CR45","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s00428-017-2211-2","volume":"471","author":"D Jiang","year":"2017","unstructured":"Jiang D, et al. Synovial sarcoma showing loss of a green signal in SS18 fluorescence in situ hybridization: a clinicopathological and molecular study of 12 cases. Virchows Arch. 2017;471(6):799\u2013807.","journal-title":"Virchows Arch"},{"issue":"5","key":"1576_CR46","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s00428-012-1306-z","volume":"461","author":"S Romeo","year":"2012","unstructured":"Romeo S, et al. Malignant fibrous histiocytoma and fibrosarcoma of bone: a re-assessment in the light of currently employed morphological, immunohistochemical and molecular approaches. Virchows Arch. 2012;461(5):561\u201370.","journal-title":"Virchows Arch"},{"issue":"3","key":"1576_CR47","first-page":"1769","volume":"41","author":"D Xing","year":"2019","unstructured":"Xing D, Lu J. Distinctive clinicopathological features and disease-specific survival of adenoid cystic carcinoma and adenoid basal carcinoma in the lower female genital tract. Oncol Rep. 2019;41(3):1769\u201378.","journal-title":"Oncol Rep"},{"issue":"1","key":"1576_CR48","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.humpath.2004.08.015","volume":"36","author":"AV Parwani","year":"2005","unstructured":"Parwani AV, et al. Cervical adenoid basal tumors comprised of adenoid basal epithelioma associated with various types of invasive carcinoma: clinicopathologic features, human papillomavirus DNA detection, and P16 expression. Hum Pathol. 2005;36(1):82\u201390.","journal-title":"Hum Pathol"},{"key":"1576_CR49","doi-asserted-by":"publisher","first-page":"1507736","DOI":"10.3389\/fmed.2024.1507736","volume":"11","author":"X Bao","year":"2024","unstructured":"Bao X, et al. Case report: multiphenotypic cervical cancer resembling human papillomavirus-related multiphenotypic sinonasal carcinoma. Front Med (Lausanne). 2024;11:1507736.","journal-title":"Front Med (Lausanne)"}],"container-title":["Cell &amp; Bioscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13578-026-01576-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-026-01576-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-026-01576-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:03:04Z","timestamp":1783468984000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13578-026-01576-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1576"],"URL":"https:\/\/doi.org\/10.1186\/s13578-026-01576-1","relation":{},"ISSN":["2045-3701"],"issn-type":[{"value":"2045-3701","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"21 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Johns Hopkins Institutional Review Board approved of the study: IRB00223822. Patient consent was waived by JHU IRB policy since this is minimal-risk research using\/involving secondary material for which consent is not required. All mouse work and procedures were performed according to the protocols approved by the Johns Hopkins Institutional Animal Care and Use Committee and in accordance with recommendations for the proper use and care of laboratory animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"75"}}